| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 02/06/2001 | CA2075974C Totally synthetic affinity reagents |
| 02/06/2001 | CA2067744C The human c3b/c4b receptor (cr1) |
| 02/06/2001 | CA2025491C Methods and materials for phe a feedback inhibition resistance |
| 02/06/2001 | CA2013544C Retinoblastoma gene product antibodies and uses therefor |
| 02/03/2001 | CA2314466A1 Lentivirus from the group of immunodeficiency viruses of drill monkeys (mandrillus leucophaeus) and their use |
| 02/02/2001 | CA2315837A1 Microbial production of levodione |
| 02/01/2001 | WO2001007630A1 Novel cytochrome p450 monooxygenases and their use for oxidizing organic compounds |
| 02/01/2001 | WO2001007626A2 Methods for producing l-amino acids by increasing cellular nadph |
| 02/01/2001 | WO2001007623A1 Epoxide hydrolases from streptomyces |
| 02/01/2001 | WO2001007574A2 Modified cytochrome p450 monooxygenases |
| 02/01/2001 | WO2001007573A1 Electron donor system for enzymes and its use for the biochemical conversion of substrates |
| 02/01/2001 | WO2001007567A1 Engineering of metabolic control |
| 02/01/2001 | WO2001007069A1 In vivo induction for enhanced function of isolated hepatocytes |
| 02/01/2001 | WO2001007066A2 Ppar delta inhibitors for the treatment of cardiovascular diseases |
| 02/01/2001 | WO2000061736A3 Recombinant and mutant marek's disease virus |
| 02/01/2001 | WO2000061727A3 Production of pancreatic procarboxy-peptidase b, isoforms and muteins thereof, and their use |
| 02/01/2001 | WO2000060095A3 Enzymes of the biosynthetic pathway for the production of triacylglycerol and recombinant dna molecules encoding these enzymes |
| 02/01/2001 | WO2000015838A3 Essential genes from c. albicans and a method for screening antimycotic substances using said genes |
| 02/01/2001 | WO2000009668A9 Engraftable human neural stem cells |
| 02/01/2001 | DE19935113A1 Epoxidhydrolasen aus Streptomyces Epoxide hydrolases from Streptomyces |
| 02/01/2001 | CA2379518A1 Electron donor system for enzymes and its use for the biochemical conversion of substrates |
| 02/01/2001 | CA2378462A1 Ppar delta inhibitors for the treatment of cardiovascular diseases |
| 02/01/2001 | CA2377693A1 Methods for producing l-amino acids |
| 01/31/2001 | EP1072677A1 Hybridoma cell line derived from 2.4G2 cell line, preferentially not expressing any mouse kappa chains |
| 01/31/2001 | EP1072611A1 Monoclonal antibody directed against the thrombin-antithrombin III complex and its use in immunoassays |
| 01/31/2001 | EP1071798A1 Novel constructs for controlled expression of recombinant proteins in prokaryotic cells |
| 01/31/2001 | EP1071779A1 Vertebrate patched-2 protein |
| 01/31/2001 | EP1071776A2 Human nucleic acid sequences of normal bladder tissue |
| 01/31/2001 | EP1071762A1 Control of gene expression |
| 01/31/2001 | EP1071761A1 Mutants of the mycobacterium species and use of the same for screening for antibiotics vectors |
| 01/31/2001 | EP1071749A1 Novel lrsg protein and nucleic acid molecules and uses therefor |
| 01/31/2001 | EP1071746A2 Process for preparing doxorubicin |
| 01/31/2001 | EP1071743A1 Method for producing and extracting aromatic compounds |
| 01/31/2001 | EP1071715A2 TRANSFERRIN RECEPTOR GENES OF $i(MORAXELLA) |
| 01/31/2001 | EP1071443A1 Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof |
| 01/31/2001 | EP0593428B1 Myconematicide |
| 01/31/2001 | CN1282376A Process for preparing xylitol |
| 01/31/2001 | CN1282375A Process for preparing xylitol |
| 01/31/2001 | CN1281863A Recombinant Newcastle disease virus capable of being used as embryo vaccine |
| 01/30/2001 | US6180760 Of given amino acid sequence, a cdna sequence, and antibody specifically recognizing 1-afadin; 1-afadin contributes to the cell-to-cell adherens junction (aj) having a role in individual formation of animals and pathigenesis |
| 01/30/2001 | US6180752 Polyasparaginic acid homopolymers an copolymers, biotechnical production and use thereof |
| 01/30/2001 | US6180614 Methods of immunization of aquaculture species by introducing dna expression systems into the aquaculture species |
| 01/30/2001 | US6180613 AAV-mediated delivery of DNA to cells of the nervous system |
| 01/30/2001 | US6180407 Cloning and/or sequencing vector |
| 01/30/2001 | US6180399 Synthetic rna having endonuclease activity and altered substrate binding site; for multifunctional enzyme |
| 01/30/2001 | US6180392 Streptomyces strains and process to produce single streptogramin component |
| 01/30/2001 | US6180388 Process for the enzymatic hydrolysis of polyamide 6.6 to give adipic acid monomers and hexamethylenediamine monomers |
| 01/30/2001 | US6180387 Nucleotide sequence coding an enzymatic polypeptide; for the detection of bactericides and batericidal agonist and antagonists which prevent bacterial infection |
| 01/30/2001 | US6180386 DNA sequences coding for the human proteins Tx and Ty related to the interleukin-1beta converting enzyme |
| 01/30/2001 | US6180385 Nucleotide sequences coding a viral enzymatic polypeptide; for the detection of modulators of proteolytic activity |
| 01/30/2001 | US6180382 Xylanase derived from a bacillus species, expression vectors for such xylanase and other proteins, host organisms therefor and use thereof |
| 01/30/2001 | US6180380 Cloning of a new member of the serine threonine kinase family |
| 01/30/2001 | US6180377 Humanized antibodies |
| 01/30/2001 | US6180373 Eschericha and cornyebacteria which are genetically engineered to produce amplified concentratons of preferential amino acids |
| 01/30/2001 | US6180371 Modified factor VIII |
| 01/30/2001 | US6180370 Preparing preferential antibodies; generating nucleotide sequences coding preferential antibodies, expressing nucleotide sequences in transformed cell and recovering preferential antibodies |
| 01/30/2001 | US6180369 Varicella-zoster virus antigen |
| 01/30/2001 | US6180366 Methods for producing heterologous polypeptides in trichothecene-deficient |
| 01/30/2001 | US6180361 Recombinant DNA expression vectors and DNA compounds that encode deacetoxycephalosporin C synthetase and deacetylcephalosporin C synthetase |
| 01/30/2001 | US6180360 Process of producing β-lactam antibiotics applying micro-organisms with increased ligase activity |
| 01/30/2001 | US6180359 Industrial scale process for the preparation of 2-hydroxy-4-methylbutyric acid using a nitrilase |
| 01/30/2001 | US6180339 Nucleic acid probes for the detection and identification of fungi |
| 01/30/2001 | US6180334 Artificial recombinant substrate (rAGG 1) and native aggrecan to determine the proteolytic activity of ‘aggrecanase’ in cell culture systems |
| 01/30/2001 | US6180110 Attenuated hepatitis a virus vaccine which grows in MRC-5 cells |
| 01/30/2001 | US6180109 Nucleotide and polypeptide sequences of pestivirus strains |
| 01/30/2001 | US6180108 For enhancing integration of expression vectors into the genomic dna in host mammalian cell lines |
| 01/30/2001 | US6180104 Can be used such as nucleotide probes, combining with foreign dna sequences to produce novel t-cell receptors, which can be used in an analogous manner as antibodies, or constructs can be provided which provide for extrachromosomal elements |
| 01/30/2001 | CA2064558C Method for inhibiting growth of stem cells |
| 01/30/2001 | CA2056997C A human cytokine, interleukin-9 |
| 01/30/2001 | CA2022610C Human gp130 protein |
| 01/30/2001 | CA2010929C Process for preparing nitriloamides |
| 01/27/2001 | CA2312626A1 A recombinant newcastle disease virus as an embryo vaccine |
| 01/25/2001 | WO2001005989A1 Method of constructing recombinant adenovirus vector |
| 01/25/2001 | WO2001005978A1 FimH ADHESIN-BASED VACCINES |
| 01/25/2001 | WO2001005960A1 Process for producing l-amino acid |
| 01/25/2001 | WO2001005426A1 Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies |
| 01/25/2001 | WO2000061156A3 Methods of treating schizophrenia |
| 01/25/2001 | DE19930959A1 Neue Antimycotika und Fungizide, Verfahren zu deren Herstellung und Verwendung New antimycotics and fungicides, processes for their preparation and use |
| 01/25/2001 | CA2379349A1 Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies |
| 01/25/2001 | CA2379069A1 Fimh adhesin-based vaccines |
| 01/24/2001 | EP1070454A1 Transgenic animal showing vascular tissue-specific expression of angiotensin ii2 receptor |
| 01/24/2001 | EP1070136A1 Strain of the microorganism penicillium oxalicum var. armeniaca and its application |
| 01/24/2001 | EP1070132A2 RECOMBINANT L-N-CARBAMOYLASE DERIVED FROM $i(ARTHROBACTER AURESCENS), AND A METHOD FOR PRODUCING L-AMINO ACIDS BY USING THE SAME |
| 01/24/2001 | EP1070128A1 Axor4 g-protein-coupled receptor |
| 01/24/2001 | EP1070119A2 Immobilized nuclease from serratia marcescens |
| 01/24/2001 | EP1070117A1 Genetic constructs and genetically modified microbes for enhanced production of beta-glucosidase |
| 01/24/2001 | EP0820471B1 Antibodies against heart muscle actin |
| 01/24/2001 | CN1281511A Polypeptides having 5-aminolevulinic acid synthase activity and nucleic acids encoding same |
| 01/24/2001 | CN1061097C Enzymatic hydrolysis method for conversion of C-7 sugar to C-7 hydroxyl taxanes |
| 01/24/2001 | CN1061095C Process for preparing glycopeptide antibiotics |
| 01/24/2001 | CN1061089C Pullulanase, microorganisms which produce it, processes for preparation of this pullulanase and uses thereof |
| 01/24/2001 | CN1060937C Use of cow mycobacteria for producing medicine for curing HIV infection patient |
| 01/23/2001 | US6177615 Lepidopteran-toxic polypeptide and polynucleotide compositions and methods for making and using same |
| 01/23/2001 | US6177458 Alzheimer's disease |
| 01/23/2001 | US6177401 Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis |
| 01/23/2001 | US6177264 Nucleotide sequences isolated from coryneform which code for ketopantoate hydroxymethyltransferase and pantothenate synthetase of defined amino acid sequences; for recombinant production |
| 01/23/2001 | US6177248 Detecting expression of at least one gene down-stream from wt1 and comparing to wild type cells; a difference suggests mutation; diagnosis of cancer/tumor |
| 01/23/2001 | US6177246 Contacting a tissue or cell with an oligonucleotide of defined nucleotide sequence which hybridizes to nucleic acid encoding abnormally expressed beta-amyloid precursor protein; prophylaxis and treatment of alzheimer's disease |
| 01/23/2001 | US6177245 Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms |
| 01/23/2001 | US6177082 Cold-adapted equine influenza viruses |